Affinivax's Unattributed Round

Affinivax raised a round of funding on February 28, 2017. Investors include Astellas Pharma.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious disease…

Articles about Affinivax's Unattributed Round: